{"database": "openregs", "table": "documents", "rows": [["FDA-2022-P-0585-0004", "FDA", "FDA-2022-P-0585", "Determination That NORFLEX (Orphenadrine Citrate) Injection, 30 Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-\nRelease Tablet, 100 Milligrams, Were Not Withdrawn From Sale for Reasons\nof Safety or Effectiveness", "Notice", "Determinations", "2022-12-08T05:00:00Z", 2022, 12, "2022-12-08T05:00:00Z", null, "2022-12-08T16:06:44Z", "2022-26663", 0, 0, "0900006485524ea2"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2022-P-0585-0004"], "units": {}, "query_ms": 6.244335090741515, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}